Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia

Shinomiya, S; Nakase, K; Fujii, A; Takahara, Y; Adachi, H; Okuro, M; Iinuma, Y; Yokoyama, H; Ito, T; Mizuno, S

Shinomiya, S (corresponding author), Kanazawa Med Univ, Dept Resp Med, 1-1 Daigaku,Uchinada Machi, Kahokugun, Ishikawa 9200295, Japan.

SAGE OPEN MEDICAL CASE REPORTS, 2021; 9 ():

Abstract

In coronavirus disease 2019 pneumonia, a cytokine storm resulting from an excessive inflammatory response to the viral infection is thought to play a ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索